BioStem Technologies

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, BioStem Technologies sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 1 currently recruiting 1 completed upper quartile by trial count

BioStem Technologies: 3 sponsored US clinical trials, 1 recruiting.

BioStem Technologies sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Non-ischemic Diabetic Foot Ulcer, with 1 trials.

Upper-quartile sponsor footprint

BioStem Technologies sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING NA

Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC

NCT06811909
ACTIVE NOT RECRUITING NA

Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM

NCT06565156
COMPLETED NA

A Prospective Trial of Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AC

NCT06511596

Therapeutic Areas

Non-ischemic Diabetic Foot Ulcer 1
Diabetic Wound 1
Non-infected Diabetic Foot Ulcer 1
Venous Reflux 1
Non-infected Venous Leg Ulcer 1
Venous Insufficiency 1
Venous Stasis 1
Venous Leg Ulcer 1
Diabetic Foot 1
Diabetic Foot Ulcer 1

What is open in the BioStem Technologies pipeline

1 recruiting of 3 indexed (33% open); 1 completed (33%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Non-ischemic Diabetic Foot Ulcer (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

BioStem Technologies: open-pipeline peers nationwide

Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

BioStem Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%10%20%30%40% Total trials Recruiting share BioStem Technologies10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAadi BioscienceAaron CookAbivax S.A.Actuated Medical
BioStem Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

BioStem Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this BioStem Technologies page

3 registered trials is a research-attention snapshot, not an endorsement of BioStem Technologies or any single study.

  • 1 of BioStem Technologies's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Non-ischemic Diabetic Foot Ulcer is the condition BioStem Technologies studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Non-ischemic Diabetic Foot Ulcer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. BioStem Technologies pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.